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ABSTRACT The Taiep rat is a myelin mutant with a motor syndrome character-
ized by tremor, ataxia, immobility, epilepsy, and paralysis. The rat shows a hypomyeli-
nation followed by a progressive demyelination. During immobilities taiep rats show a
REM-like sleep pattern and a disorganized sleep-wake pattern suggesting taiep rats
as a model of narcolepsy-cataplexy. Our study analyzed the role of postsynaptic
serotonin receptors in the expression of gripping-induced immobility episodes (IEs) in
8-month-old male taiep rats. The speciﬁc postsynaptic serotonin agonist 61-(2,5-dime-
thoxy-4-iodoamphetamine hydrochloride (6DOI) decreased the frequency of gripping-
induced IEs, but that was not the case with a-methyl-serotonin maleate (a-methyl-
5HT), a nonspeciﬁc postsynaptic agonist. Although the serotonin antagonists, ketan-
serine and metergoline, produced a biphasic effect, ﬁrst a decrease followed by an
increase with higher doses, similar effects were obtained with a mean duration of grip-
ping-induced IEs. These ﬁndings correlate with the pharmacological observations in
narcoleptic dogs and humans in which serotonin-reuptake inhibitors improve cata-
plexy, particularly in long-term treatment that could change the serotonin receptor
levels. Polysomnographic recordings showed an increase in the awakening time and a
decrease in the slow wave and rapid eye movement sleep concomitant with a decrease
in immobilities after use of 6DOI, this being stronger with the highest dose. Taken to-
gether, our results show that postsynaptic serotonin receptors are involved in the mod-
ulation in gripping-induced IEs caused by the changes in the organization of the
sleep-wake cycle in taiep rats. It is possible that speciﬁc agonists, without side effects,
could be a useful treatment in human narcoleptic patients. Synapse 63:737–744,
2009. V V C 2009 Wiley-Liss, Inc.
INTRODUCTION
The myelin-mutant taiep rat, an acronym of tremor,
ataxia, immobility episodes, epilepsy, and paralysis,
was obtained spontaneously during the process of
inbreeding of the Sprague-Dawley rat to obtain a high-
yawning subline at the Institute of Physiology of
the Beneme ´rita Universidad Auto ´noma de Puebla
(Holmgren et al., 1989). The taiep rat shows an initial
hypomyelination followed by a progressive demyelin-
ation in the central, but not in the peripheral, nervous
system (Couve et al., 1997; Duncan et al., 1992). At an
ultrastructural level, the oligodendrocytes of taiep rats
showed an abnormal accumulation of microtubules in
the cytoplasm and its processes (Couve et al., 1997;
Duncan et al., 1992). The excess of microtubules dis-
rupt the transporting mechanisms in glia cells (Couve
et al., 1997; O’Connor et al., 2000). These alterations
impact the relationship between glia and neuron that
alters the synaptic transmission in various pathways
(Bonansco et al., 2004, 2007; Fuenzalida et al., 2004;
Roncagliolo et al., 2000, 2006).
By using continuous polysomnographic recordings
across a light–dark period, we are able to evaluate
spontaneous and gripping-induced immobility epi-
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SYNAPSE 63:737–744 (2009)sodes on the male taiep rat. During IEs, taiep rats
show a REM sleep-like pattern, which has been
shown to be a cortical desynchronization associated
with the theta rhythm in the hippocampus (Corte ´s
et al., 2005). Taiep rats also show an alteration of the
sleep pattern with disorganized wake and sleep peri-
ods. This myelin mutant shows a pattern of disorgan-
ized REM sleep similar to that seen in canine and
human narcolepsy (Aldrich, 1992; Nishino and
Mignot, 1997).
Human narcolepsy is considered a disorder of REM
sleep, and it is characterized by excessive daytime
sleepiness, cataplexy, sleep paralysis, hypnagogic hal-
lucinations, and a disrupted nocturnal sleep (Aldrich,
1992). Several lines of evidence relate narcolepsy to a
dysfunction of the cholinergic and the monoaminergic
neurotransmitter mechanisms that are critically
involved in the regulation of wake-sleep cycle
(Aldrich, 1992). Several studies suggest that a postsy-
naptic serotonin receptor, the (5-HT2) subtype, plays
a role in the regulation of sleep (Dugovic et al., 1989),
but until now it is not clear what their site of action
is (Amici et al., 2004). However, systemic administra-
tion of either the agonists 62,5-dimethoxy-4-bromo-
amphetamine hydrobromide (6DOB), 61-(2,5-dime-
thoxy-4-iodoamphetamine hydrochloride (6DOI), or
the antagonists ritanserine and (2-(2-dimethylamino
ethylthio)-3-phenyl quinoline (ICI 169,369) of the 5-
HT2 subtype produced a signiﬁcant decrease in the
REM sleep of the rat (Dugovic et al., 1989; Tortella
et al., 1989).
The serotonergic system has also been implicated
in the pathology of human and canine narcolepsy
(Nishino and Mignot, 1997). The systemic administra-
tion of clomipramine and zimelidine, two serotonergic
uptake inhibitors, has a potent anticataplexic effect
in human narcolepsy (Langdon et al., 1986); whereas
ritanserine, a 5-HT2 receptor antagonist, reduces sub-
jective sleepiness in human narcolepsy (Lammers
et al., 1991). In canine narcolepsy, the serotonergic
drugs modify the susceptibility to cataplexy in the
food-elicited-cataplexy test (FECT) (Nishino and
Mignot, 1997). Systemic administration of a 5-HT1A
receptor agonist such as 8-hydroxy-2-(di-n-propyla-
mino) tetraline hydrobromide (8-OH-DPAT) reduces
canine cataplexy (Nishino et al., 1997) and also in the
taiep rat (Ita et al., 2009). It has also been postulated
that the anticataplexic action of serotonergic uptake
inhibitors are mediated through the suppression of
REM sleep (Nishino et al., 1997).
Pharmacological data showed several similarities
between narcoleptic dogs and taiep rats. Hence, sys-
temic administration of antidrepressants and other
inhibitors of the monoamine-recapture mechanisms
decreased gripping-induced IEs (Corte ´s et al., 2000;
Gavito, 2001). Though prazosin severely increased the
frequency of gripping-induced IEs (Corte ´s et al.,
2007), a2-adrenergic agonists signiﬁcantly increased
the number of gripping-induced IEs, though the oppo-
site happens with a2 antagonists, particularly yohim-
bine, which nulify immobilities (Eguibar et al., 2006).
Recently, we showed that 5-HT1A agonists increased
the frequency of gripping-induced IEs (Ita et al.,
2009). Similar results are obtained in the narcolepic
dogs (for a review see Nishino and Mignot, 1997).
In our present study, we explored the role of the 5-
HT2 agonists and antagonists on the gripping-induced
immobility episodes and, in a second experiment, af-
ter 6DOI administration in adult taiep rats.
MATERIALS AND METHODS
General methodology
The experiments were made on taiep rats supplied
by our animal room facilities. The animals were
under a 12:12 light–dark cycle, with lights on at
07:00, with a controlled temperature 218C 6 28C, and
relative humidity between 30 and 45%. The animals
were maintained in collective acrylic cages with free
access to balanced rodent pellets (Zeigler) and tap
water. The procedures described have been done in
compliance with the policies of the Society for the
Neuroscience for scientiﬁc research, with the guide-
lines of the Laws and Codes approved in the Seventh
title of the Regulations of the General Law of Health
regarding Health Research of the Mexican govern-
ment (Norma Oﬁcial Mexicana NOM-062-Z00-1999),
and in accordance with the NIH guideline revised
2007; Clark, 2002).
Experiment 1. Role of postsynaptic
serotonin agonists and antagonists
on gripping-induced IEs
The purpose of this study was to determine the role
of systemic injection of postsynaptic serotonergic
agonists and antagonists on gripping-induced IEs in
male taiep rats.
The compounds used in these studies were 61-(2,5-
dimethoxy-4-iodoamphetamine hydrochloride (6DOI),
a-methyl-serotonin maleate (a-methyl-5HT), metergo-
line maleate, and ketanserine tartrate. All drugs
were obtained from RBI (USA) and dissolved in ster-
ile water. All solutions were freshly prepared at the
beginning of each experimental session and injected
intraperitoneally (i.p.) into male rats (n 5 6–8 rats/
drug). The injection volume for all drugs was adjusted
to 1 ml/kg. Sterile water served as the control injection.
The onset of the IEs was characterized by immobil-
ity with a sudden loss of the antigravity reﬂexes, con-
tracture of facial musculature with the ears lying
back behind the cranium producing a characteristic
facies. The IEs was associated with a generalized
increase of the muscle tone, including the ﬂexors and
extensors in the hindlimbs and hyperextension of the
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ments (Corte ´s et al., 2005). When the animal recovers
its normal facial expression, muscle tone, and starts
vertical movements of the head and locomotion, this
was taken as the end of the IE (Corte ´s et al., 2005).
To habituate the animals to the test environment,
the taiep rats were transferred to the experimental
room 20 minutes before the experiment. The test was
done in acrylic cages (21 3 24.5 3 35 cm). All tests
began at 08:00 AM, which coincides with a peak in
the susceptibility of the gripping-induced immobility
episodes (Corte ´s et al., 2005). All animals ﬁrst
received a control sterile water injection to have a ba-
sal response of gripping-induced IEs. The ip injection
was made with an increasing dose every 48 hours.
The doses used in the study were 1, 3, 10, 30, 100,
300, and 1000 lg/kg of agonists 6DOI and a-methyl-
5-HT or antagonists ketanserine and metergoline of
serotonergic-postsynaptic receptors (5-HT2).
The immobility was caused by gripping the rat
from the base of the tail (1–2 cm from the base) every
5 minutes, because this is the best way to cause IEs
(Corte ´s et al., 2005). The IE frequencies were scored
cumulatively at 5-minute intervals for the next 90
minutes after drug injection. We also recorded the
total duration of each immobility episode, the elapsed
time from the onset of the session, and the time of
the ﬁrst immobility episode.
Thirty seconds before the gripping-induced IE, we
measured the state of the activity of the rats with a
behavioral-activation scale of 0–4 points, with 0 indi-
cating somnolence, 1 quiet rat, 2 low activities such
as snifﬁng and horizontal head movements, 3 regular
level of activity as grooming, scratching, and locomo-
tion, and 4 high activity indicating displacement,
rearing, or even jumping behavior (Eguibar et al.,
2006). In this way it was possible to evaluate the gen-
eral state of the animal and also this is an indirect
way to evaluate the possible side effects produced by
the drugs tested.
Data were analyzed by repeated measures analysis
of variance. The signiﬁcant overall effects between
treatment and control group were evaluated with a
post hoc Dunn’s test using Sigma Stat 3.0 under
Windows Vista software. P < 0.05 was considered as
statistically signiﬁcant.
Experiment 2. Polysomnographic recordings to
determine the changes in the sleep-wake cycle
and on spontaneous immobilities in taiep rats
after systemic injection of 6DOI
EEG recordings
The sleep-wake cycle and spontaneous IEs were
recorded during an 8-hour EEG on male taiep rats,
by using a video electroencephalographic recording
system (Stellate System, Canada). Two stainless steel
electrodes were implanted into the cerebral cortex in
frontal and parietal areas, two stainless steel wires
were introduced into the neck muscles, another one
in the eye’s orbit, and one bipolar electrode in the
CA1 region of the hippocampus in rats, all under cho-
ral hydrate anesthesia (300 mg/kg) and under the ste-
reotaxic coordinates from Paxinos and Watson (2007)
using a Kopft stereotaxic frame.
After recovery from surgery (second day), the ani-
mals were habituated to the recording room (day 3–
7). During the ﬁrst 3 days the rats received s.c. injec-
tions of antibiotic (tilosine tartrate, 50 mg/kg) and an-
algesic (metamizole sodium, 40 mg/kg) and were
under the strict vigilance of a veterinary physician.
While lying in Plexiglas cages, they were prevented
from twisting their bodies but otherwise able to move
their bodies and limbs relatively freely. They were
able to sleep in a curled position. EEG and EMG sig-
nals were ampliﬁed, ﬁltered, and digitized at 200 Hz
by using an analog-digital board for recording and
analysis using EEG and sleep-wake (Harmonie ver-
sion 5.2; Stellate Co., Canada). A video recording of
the rats’ behavior was also acquired simultaneously
by the same software.
Each record was scored off-line by visual assess-
ment for classiﬁcation of 10-second epochs according
to the sleep-wake state. The EEG and EMG activities
were considered together with the behavioral scores
to determine them as awake (W), in slow wave sleep
(SWS), or in rapid eye movement (REM) sleep. On
the basis of visually scored records, sleep-wake hyp-
nograms were generated in 10-second epochs and
data acquired over 8 hours using LUNA software
(Stellate Systems). The EMG amplitude was com-
puted for the total spectrum up to 60 Hz. The EEG
and EMG data for the ﬁgures were plotted with
Microcal Origin software v. 9.0. We recorded every 8
hours the ﬁrst day and every 48 hours thereafter the
effects of three different doses of 6DOI using a latin-
square design to avoid accumulative effects.
Data were analyzed by repeated measures analysis
of variance. The signiﬁcant overall effects between
treatment and control group were evaluated with a
post hoc Dunn’s test using Sigma Stat 3.0 under Win-
dows Vista software.
RESULTS
The participation of postsynaptic serotonin recep-
tors on the frequency of gripping-induced IEs was
determined after injection of agonists and antagonists
of the 5-HT2 receptor subtype. Figure 1A showed that
6DOI, a 5-HT2A selective agonist, produced a dose-
dependent decrease in the frequency of gripping-
induced IEs, with this being signiﬁcant between
100 o 1000 lg/kg compared with saline-treated (con-
trol) rats (v
2 test 5 26.8, df 5 7, P < 0.001, followed
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est dose produced almost a complete cessation of grip-
ping-induced IEs with just 1 of 108 possible immobil-
ities, with 18 IEs/rat the maximum. The injection of
a-methyl-5HT, a nonspeciﬁc 5-HT2 agonist (Fig. 1B),
had no signiﬁcant effect on the frequency of gripping-
induced IEs (v
2 test 5 8.7, df 5 7, P 5 0.3).
Figure 1C showed that injection of a speciﬁc ago-
nist, 6DOI, produced a clear dose-dependent decrease
in the mean duration of gripping-induced IEs and
was signiﬁcant with the highest doses (300 and 1000
lg/kg; v
2 test 5 29.1, df 5 7, P < 0.001; followed by
the Dunn’s test, P < 0.05). However, the injection of
a-methyl-5 HT caused a signiﬁcant increase in the
mean duration of gripping-induced IEs with higher
doses (v
2 test 5 15.4, df 5 7, P < 0.03; followed by
the Dunn’s test, P < 0.05, see Fig. 1D).
The injection of the 5-HT2 antagonist ketanserine
produced a biphasic effect, an initial decrease in the
frequency of gripping-induced IEs, being signiﬁcant
between 10 and 30 lg/kg (v
2 test 5 29.5, df 5 10, P <
0.002; followed by the Dunn’s test, P < 0.05, see Fig.
2A). Metergoline, 5-HT2 antagonist, also appeared to
cause a biphasic effect, showing nonsigniﬁcant differ-
ences among the doses (H 5 17.6, df 5 7, P < 0.01).
The mean duration of gripping-induced IEs increased
with the higher doses after ketanserine injections (H
5 41.9, df 5 10, P < 0.001, followed by the Dunn’s
test, P < 0.05, see Fig. 2C), and this was also true
with metergoline (H 5 36.9, df 5 8, P < 0.001, fol-
lowed by the Dunn’s test, P < 0.05, see Fig. 2D).
Table I showed the effects of injection of agonists
and antagonists of serotonin 5-HT2A receptors in the
latency to the ﬁrst gripping-induced IE. A signiﬁcant
increase in the latency was obtained only with high-
est doses of 6DOI (300 and 1000 lg/kg; v
2 test 5
16.9, df 5 7, P < 0.02; followed by the Dunn’s test, P
< 0.05). The nonspeciﬁc serotonin agonist a-methyl-5
HT did not signiﬁcantly change the latency to ﬁrst
immobility (v
2 test 5 7.9, df 5 7, P 5 0.34). Ketanser-
ine did not signiﬁcantly modify the latency (v
2 test 5
11.9, df 5 6, P 5 0.06), and similar results were
obtained with metergoline (v
2 test 5 9.7, df 5 5, P 5
0.08).
Fig. 1. Effects of serotonergic-postsynaptic agonists on gripping-
induced IEs in male taiep rats. All values are means 6 SE. A: Injec-
tion of 6DOI produces a signiﬁcant decrease of immobilities with
the three higher doses (P < 0.001, followed by Dunn’s, P < 0.05). B:
a-Methyl-5 HT does not show any signiﬁcant effect. C: 6DOI pro-
duces a signiﬁcant decrease in the mean duration of gripping-
induced IEs with the higher doses P < 0.001, followed by Dunn’s, P
< 0.05). D: a-Methyl-5 HT signiﬁcantly increased the mean duration
of immobilities at all doses tested P < 0.03, followed by Dunn’s, P <
0.05).
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tion of either agonists or antagonists of the 5-HT2A
receptor. The injection of 6DOI caused an increase in
the behavioral score caused by head twitches, a hori-
zontal movement of short duration of 1 or 2 seconds
(v
2 test 5 29.1, df 5 7, P < 0.001; followed by the
Dunn’s test, P < 0.05) only with the highest dose.
However, a-methyl-5 HT did not change the behav-
ioral score (v
2 test 5 10.95, df 5 7, P 5 0.14). Meter-
goline also did not produce any change on the behav-
ioral score (v
2 test 5 1.95, df 5 7, P 5 0.96), whereas
the speciﬁc 5-HT2A-agonist ketanserine produced the
opposite effect, a decrease in the behavioral score
(300 and 1000 lg/kg; v
2 test 5 27.14, df 5 6, P <
0.001; followed by the Dunn’s test, P < 0.05), with
some tendency to somnolence and a ﬂat body posture
accompanied with hindlimb abduction, similar to that
observed in the serotonergic syndrome (Darmani and
Gerdes, 1995).
Results experiment 2
Because of the strong decrease in gripping-induced
IEs produced by injection of 6DOI, a speciﬁc agonist
of postsynaptic serotonin receptors. We decided to an-
alyze the effects of this drug on the distribution of the
Fig. 2. Serotonergic-postsynaptic antagonists decrease gripping-
induced immobility episodes. A: Ketanserine produced a signiﬁcant
decrease in gripping-induced IEs between 3 and 100 lg/kg P <
0.002, followed by Dunn’s, P < 0.05). B: Metergoline produced a
biphasic effect; a decrease between 1 and 30 lg/kg and then an
increase with the higher doses (P < 0.01). C: Ketanserine signiﬁ-
cantly increased the mean duration with the highest dose (P <
0.001, followed by Dunn’s, P < 0.05). D: Metergoline signiﬁcantly
increased the mean duration of IEs with the higher doses, 300 and
1000 lg/kg (P < 0.001, followed by Dunn’s, P < 0.05).
TABLE I. Latency to ﬁrst IEs after agonists and antagonists administration
Treatment
Dose (lg/kg)
Control 1 3 10 30 100 300 1000
6DOI 27 6 13 2 6 13 7 6 84 5 6 13 2 6 85 9 6 17 6 6 1
a 76 6 1
a
a-Methyl-5HT 8 6 18 6 21 8 6 52 5 6 11 9 6 71 9 6 52 5 6 96 6 1
Ketanserine 29 6 83 1 6 13 9 6 16 2 6 75 9 6 94 6 6 73 0 6 61 6 6 3
Metergoline 37 6 14 8 6 15 9 6 16 4 6 12 68 6 15 4 6 94 8 6 83 0 6 8
Six rats were evaluated with each drug. Data are means 6 SE.
aSigniﬁcant different from saline-treated animals (v
2 test P < 0.02 followed by Dunn’s P < 0.05).
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injection of several doses of this drug. For this pur-
pose we analyzed the time-distribution of awake, slow
wave sleep (SWS), rapid eye movement sleep (REM),
and the effects on the frequency of spontaneous IEs.
Injection of 6DOI increased awakening time and
reduced the slow wave sleep and REM sleep (see Fig. 3
and Table III). These results showed that there is a
progressive increase in the waking time from 4.2%
with 100 lg/kg to 16% with 1000 lg/kg of 6DOI,
being statistically signiﬁcant (H 5 8.7, df 5 3, P <
0.03; followed by the Dunn’s test, P < 0.05). Concomi-
tantly, a reduction in the SWS, about 11% with the
highest dose (H 5 8.9, df 5 3, P < 0.03; followed by
the Dunn’s test, P < 0.05) and almost a cessation of
REM sleep with just 0.4% of total sleep time (TST;
H 5 8.5, df 5 3, P < 0.03; followed by the Dunn’s
test, P < 0.05). These results showed that postsynap-
tic serotonin activation produced cortical activation in
taiep rats. Injection of 6DOI also decreased the fre-
quency of spontaneous IEs from 14.2 6 7.8 in saline-
treated taiep rats to 6.5 6 4.2 IEs after a 1000 lg/kg
injection (H 5 8.9, df 5 3, P < 0.03; followed by the
Dunn’s test, P < 0.05). It is clear also that 6DOI
increased the latencies for the ﬁrst episode of SWS
and REM sleep and decreased the frequency of spon-
taneous IEs in a dose-dependent manner (see Fig. 3).
DISCUSSION
Injection of 6DOI produced a clear decrease in the
gripping-induced IEs, and with the highest dose
(1000 lg/kg) almost a cessation of them (see Fig. 1A),
with similar effects obtained during 8-hour EEG
recordings with a signiﬁcant decrease of spontaneous
IEs. It is quite clear that this 5-HT2 receptor agonist
TABLE II. Behavioral response to systemic administration of agonists and antagonists of serotonin receptors in taiep rats
Treatment
Dose (lg/kg)
Control 1 3 10 30 100 300 1000
6DOI 1.1 6 0.1 1.0 6 0.1 1.0 6 0.0 1.0 6 0.1 0.8 6 0.0 1.3 6 0.1 1.8 6 0.2 1.9 6 0.1
a
a-Methyl-5HT 1.0 6 0.1 0.9 6 0.1 0.9 6 0.1 0.9 6 0.1 0.8 6 0.1 0.9 6 0.1 0.8 6 0.1 0.7 6 0.0
Ketanserine 1.0 6 0.1 0.8 6 0.1 1.0 6 0.1 1.0 6 0.1 0.9 6 0.1 0.8 6 0.1 0.6 6 0.1 0.4 6 0.1
a
Metergoline 1.0 6 0.1 1.2 6 0.1 1.1 6 0.0 1.1 6 0.1 1.1 6 0.1 1.1 6 0.1 1.1 6 0.1 1.1 6 0.1
Six rats were evaluated with each drug. Data are means 6 SE.
aSigniﬁcant different from saline-treated animals (v
2 test P < 0.02 followed by Dunn’s P < 0.05).
Fig. 3. Hypnograms under control conditions and after injection
of different doses of 6DOI. A: Control hypnogram after i.p. saline
injection on 8-month-old male taiep rats. B: After 100 lg/kg of
6DOI, the latencies to SWS and REM sleep are larger. C: A clear
decrease in the total sleep time and the frequency of spontaneous
IEs is obtained after the injection of 6DOI at 300 lg/kg. D: Maxi-
mum effects are obtained with 1000 lg/kg of 6DOI with an increase
in the awakening time and a signiﬁcant reduction of the SWS and
REM sleep patterns (P < 0.03, followed by Dunn’s, P < 0.05). Note
a progressive signiﬁcant decrease in the frequency of spontaneous
IEs after 6DOI (P < 0.03).
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tant decrease of SWS and REM sleep, as has been
reported in normal rats (Amici et al., 2004; Dugovic
et al., 1989). These results clearly supported our pro-
posal that the IE is a REM-like sleep pattern (Corte ´s
et al., 2005). The behavioral analysis made on taiep
rats clearly showed that 6DOI produced head
twitches, a sign of a serotonergic syndrome indicating
a strong activation of serotonin-postsynaptic receptors
(Darmani and Gerdes, 1995; Darmani et al., 1990;
Tricklebank, 1985).
The role of serotonergic 5-HT2 receptors has only
been marginally studied in the narcoleptic dog because
these compounds produced several side effects, which
did not allow the evaluation of dose–response curves
in narcoleptic dogs (Nishino and Mignot, 1997). Addi-
tionally ritanserine, a 5-HT2 antagonist, only produced
a marginal reduction of cataplexy caused by the food-
elicited-cataplexy test (Nishino and Mignot, 1997).
However, in taiep rats it showed clear results with a
decrease of SWS and REM sleep and in the frequency
of spontaneous of IEs, with an increase of awakening
time after 6DOI injection, particularly with the high-
est doses (see Table III).
The role of the nucleus raphe dorsalis is well estab-
lished in sleep because the discharge frequency of
these neurons is tonically active during waking, reduc-
ing discharge during non-REM sleep, and ceasing or
nearly ceasing discharge during REM sleep (McGinty
and Harper, 1976; Steininger et al., 1999). Muscle tone
suppression is also closely linked to the cessation of
monoamine release to motoneurons (Lai et al., 2001;
Mileykovskiy et al., 2000). Most important is that cats,
in which REM sleep without atonia had been caused
by pontine lesions, had substantial dorsal raphe activ-
ity in REM sleep, in contrast to the normal cessation
of activity during this state (Trulson and Jacobs,
1979). However, in narcoleptic dogs these REM-off
neurons only partially reduced their activity (Wu
et al., 2003), indicating the participation of serotonin
neurons in normal and abnormal sleep patterns.
The noradrenergic and median pontine reticular
nuclei reduce discharge before and during cataplexy
(Siegel et al., 1991, 1992) and this is associated with
an increase of GABA and glycine release into moto-
neurons (Kodama et al., 2003). Coordinated activation
of brainstem inhibitory systems and an inactivation of
facilitatory systems appear to be responsible for both
REM sleep atonia and the loss of muscle tone in cata-
plexy (Chase et al., 1989; Mileykovskiy et al., 2000).
We do not know what the serotonergic discharge
pattern is in taiep rats, but it is clear that serotonin
5HT1 receptors decreased gripping-induced IEs and
antagonists increased them with the higher doses,
probably caused by the postsynaptic action as sug-
gested in narcoleptic dogs (Nishino and Mignot,
1997). Current results also showed that the 5-HT2-
subtype serotonin receptors are involved in the sus-
ceptibility to immobilities caused by gripping them
from the tail. Taiep rats showed a disorganized sleep-
wake cycle with a lower number of sleep episodes and
a longer mean suggesting that the taiep rat is an
adequate model to study the expression of narcolepsy-
cataplexy pharmacologically. It is also clear that the
taiep rat could be an alternative model of narcolepsy-
cataplexy with a different genetic background when
compared with narcoleptic dogs and humans.
For narcoleptic dogs the disease is transmitted as a
single autosomal recessive gene with full penetrance
(Baker et al., 1982; Mignot et al., 1991). After a large
screening of genetic markers, including minisatellite
probes and positional cloning, it was clearly deter-
mined that narcoleptic dogs have an alteration in the
orexin/hypocretin receptor type-2 (Chemelli et al.,
1999). For taiep rats the neurological syndrome is
acquired as an autosomal recessive illness (Duncan
et al., 1992; Holmgren et al., 1989) affecting the cen-
tral, but not peripheral myelin (Duncan et al., 1992).
The rat showed a hypomyelination followed by a pro-
gressive demyelination (Lunn et al., 1997) caused by
an accumulation of microtubules in the cytoplasm
and its processes (Couve et al., 1997; Duncan et al.,
1992). At the genetic level the alteration in taiep rats
is located near the microtubule-associated proteins in
the chromosome 9 (Li et al., 2003), which disrupts the
transport mechanisms in these glial cells (Couve
et al., 1997; O’Connor et al., 2000; Song et al., 1999).
Additional experiments are necessary to address the
role of orexins hypocretins on the immobilities in
taiep rats, particularly taking into account that these
peptides activate the raphe serotonergic system to
improve wakefulness (De Lecea, 2008).
However, both models have similar responses after
a sudden stimulus, i.e., immobilities with a REM-like
sleep pattern (Corte ´s et al., 2005), similar to that of
narcoleptic dogs (Nishino and Mignot, 1997) and also
similar to pharmacological responses caused by a1
antagonists, a2 agonists, and 5 HT1a agonists (Corte ´s
et al., 2005; Eguibar et al., 2006; Ita et al., 2009) and
also in narcoleptic dogs (Nishino and Mignot, 1997).
The speciﬁc serotonin reuptake inhibitors improve
cataplexy in narcoleptic dogs and taiep rats (Gavito,
2001; Nishino and Mignot, 1997). However, taiep rats
TABLE III. Effects of 6DOI injection on sleep-wake cycle
and immobilities
Treatment Wake (%) SWS (%) REM (%) IEs (%)
0( lg/kg) 52.4 6 2.9 43.5 6 3.1 1.8 6 0.6 2.3 6 0.4
100 (lg/kg) 56.6 6 3.0 39.8 6 2.7 1.1 6 0.6 2.5 6 0.6
300 (lg/kg) 62.6 6 1.4 34.4 6 2.3 1.6 6 0.9 1.4 6 0.2
1000 (lg/kg) 65.9 6 3.6
a 32.5 6 3.4
a 0.4 6 0.0
a 1.2 6 0.2
a
Six rats were evaluated. Data are means 6 SE.
SWS 5 slow wave sleep, REM 5 rapid-eye movement sleep, IEs 5 immobility
episodes.
aSigniﬁcantly different from saline-treated animals (Kruskal-Wallis P < 0.03
followed by the Dunn’s test, P < 0.05).
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Synapseshowed fewer side effects that allow us to analyze the
role of different serotonin receptors on gripping-
induced IEs. In this rat narcoleptic model, it is possi-
ble to do detailed pharmacological studies.
In conclusion, gripping-induced IEs are modulated
by serotonin-postsynaptic receptors in male taiep rats.
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